How Gujarat Ambuja Exports’s new plant is helping them achieve 300% capacity expansion by 2028

Synopsis: Gujarat Ambuja Exports has commenced commercial production at its 30,000 TPA Sodium Gluconate plant in Hubli, marking its entry into maize fermentation products, with plans to expand total capacity to 1,20,000 TPA by 2028.

The company manufactures corn starch and soya derivatives, feed ingredients, cotton yarn, and edible oils, serving food, pharmaceutical, feed, and other industries within the agro-processing sector is in the spotlight after it plans to expand its capacity by 300% by 2028.

With a market capitalisation of Rs. 5,694 cr, the shares of Gujarat Ambuja Exports Ltd are currently trading at Rs. 124 per share, increasing over 7% in today’s market session, making a high of Rs. 125, from its previous close of Rs. 116.50 per share.

News

Gujarat Ambuja Exports Ltd (GAEL) has successfully commenced commercial production at its new Sodium Gluconate manufacturing facility in Hubli, Karnataka, on 19th December 2025 at approximately 9:45 a.m. This plant is India’s first maize starch-based fermentation facility for producing Sodium Gluconate, with an initial installed capacity of 30,000 TPA.

The commencement of commercial operations at this facility marks a significant milestone in GAEL’s strategic expansion into maize fermentation–based products. The company aims to leverage this state-of-the-art facility to introduce additional fermentation-based products in the coming years, thereby strengthening its position in the specialty chemicals sector.

GAEL plans to scale up the capacity of its maize fermentation based products to an aggregate installed capacity of 1,20,000 TPA by 2028, reflecting a 300% expansion from the current capacity. This growth strategy aligns with the company’s focus on innovation, sustainability, and catering to both domestic and international demand for specialty chemicals.

This strategic expansion not only enhances GAEL’s production capabilities but also reinforces its long-term vision of becoming a leading player in maize starch–based fermentation products globally.

About the company 

Gujarat Ambuja Exports Ltd (GAEL) is an Indian company specializing in the production and export of chemicals and fermentation-based products. Known for its focus on innovation and sustainability, GAEL operates advanced manufacturing facilities, including India’s first maize starch–based Sodium Gluconate plant, and serves domestic and international markets.

For the Q2FY26, the company reported sales of Rs. 1,487 crore, a 32% year-on-year increase from Rs. 1,125 crore in Q2FY25. EBITDA declined to Rs. 75.8 crore, down 31% YoY from Rs. 110 crore, and net profit fell to Rs. 38 crore, a 45% decrease from Rs. 69.3 crore. Consequently, EPS dropped to Rs. 0.83, down 45% year-on-year. The company reports a ROCE of 11.5% and an ROE of 8.59%, while maintaining a low debt-to-equity ratio of 0.09.

Written by Manideep Appana

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post How Gujarat Ambuja Exports’s new plant is helping them achieve 300% capacity expansion by 2028 appeared first on Trade Brains.